Articles with "non responder" as a keyword



Photo from wikipedia

Non-responder phenotype reveals apparent microbiome-wide antibiotic tolerance in the murine gut

Sign Up to like & get
recommendations!
Published in 2021 at "Communications Biology"

DOI: 10.1038/s42003-021-01841-8

Abstract: Broad spectrum antibiotics cause both transient and lasting damage to the ecology of the gut microbiome. Antibiotic-induced loss of gut bacterial diversity has been linked to susceptibility to enteric infections. Prior work on subtherapeutic antibiotic… read more here.

Keywords: tolerance; antibiotic treatment; non responder; gut ... See more keywords

Clinical Efficacy of Alternative TNF Inhibitor and Secukinumab Between Primary Non-Responder and Secondary Non-Responder of Prior TNF Inhibitor in Ankylosing Spondylitis.

Sign Up to like & get
recommendations!
Published in 2022 at "Modern rheumatology"

DOI: 10.1093/mr/roac005

Abstract: OBJECTIVE To compare the drug retention times and clinical efficacy of alternative tumor necrosis factor inhibitors (TNFi) and secukinumab in primary and secondary non-responders with ankylosing spondylitis (AS). METHODS AS patients treated with biologics and… read more here.

Keywords: non; secondary non; non responder; clinical efficacy ... See more keywords

Structural and clinical changes in previously treated type 1 macular neovascularization in non-responder AMD eyes switched to brolucizumab.

Sign Up to like & get
recommendations!
Published in 2023 at "European journal of ophthalmology"

DOI: 10.1177/11206721231174491

Abstract: PURPOSE To examine structural and clinical changes in previously treated type 1 macular neovascularization (MNV) in non-responder age-related macular degeneration (nAMD) eyes switched to brolucizumab. Subretinal hyper-reflective material (SHRM), intraretinal (IRF) and subretinal fluid (SRF)… read more here.

Keywords: non responder; responder; changes previously; clinical changes ... See more keywords

Brolucizumab effectiveness in pigment epithelium detachment due to exudative AMD in naïve treatment or non-responder patients

Sign Up to like & get
recommendations!
Published in 2024 at "European Journal of Ophthalmology"

DOI: 10.1177/11206721241238391

Abstract: Purpose To investigate outcomes after Brolucizumab injection in naïve treatment or non-responder patients with exudative age-related macular degeneration (AMD). Methods It is a retrospective, comparative, cohort study conducted at the tertiary referral center of the… read more here.

Keywords: treatment; non responder; amd; group ... See more keywords

Predictive Value of Interleukin 6 and Interleukin 8 in Response to Treatment of Hepatitis C Virus.

Sign Up to like & get
recommendations!
Published in 2024 at "Clinical laboratory"

DOI: 10.7754/clin.lab.2024.240119

Abstract: BACKGROUND Chronic hepatitis C (CHC) infection is a major public health problem in many low- and middle-income countries. The study aimed to find out how interleukin IL-6 and IL-8 levels in the blood affect the… read more here.

Keywords: treatment; non responder; response; hepatitis ... See more keywords